TrialJournal for immunotherapy of cancer2021

Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial.

Bo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.